BrainsWay to Present Expanded Post-Marketing Clinical Research for Major Depressive Disorder at Clinical TMS Society
May 04, 2022 08:00 ET
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, May 04, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay Launches #DontMissAnotherMoment Social Media Campaign to Promote Mental Health Awareness Month
May 02, 2022 08:46 ET
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Israel, May 02, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive...
BrainsWay to Report First Quarter Financial Results on May 11, 2022
April 27, 2022 08:00 ET
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, April 27, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay Appoints Dr. Joachim Seidel as Vice President of Corporate Development and Strategy
March 28, 2022 08:00 ET
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, March 28, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay to Host Key Opinion Leader Webinar on Deep TMS™ Therapy for Treating Anxious Depression
March 15, 2022 08:00 ET
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, March 15, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay Reports Fourth Quarter and Full-Year 2021 Financial Results and Operational Highlights
March 09, 2022 07:30 ET
|
BrainsWay
Revenue Growth of 34% in 2021, with Record Quarterly and Annual Revenues Continued Progress in Expanding FDA Labeling for Deep TMS™ and Increasing Payor Coverage Conference call to be held today,...
BrainsWay to Present at the 32nd Annual Oppenheimer Healthcare Conference
March 01, 2022 08:00 ET
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, March 01, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay to Report Fourth Quarter and Full Year 2021 Financial Results on March 9, 2022
February 28, 2022 08:00 ET
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Feb. 28, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay Announces Publication of Results Demonstrating Efficacy of Deep TMS™ in Treating Anxiety Symptoms Comorbid to Depression
February 23, 2022 08:00 ET
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Feb. 23, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 01, 2022 08:00 ET
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Feb. 01, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...